Immediate Impact
61 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Works of Ulla Peen being referenced
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ulla Peen | 151 | 185 | 16 | 68 | 8 | 231 | |
| E. Hitt Nichols | 86 | 222 | 4 | 80 | 5 | 254 | |
| Margaret Hill | 174 | 134 | 8 | 103 | 7 | 289 | |
| K.M. Bell-McGuinn | 108 | 151 | 6 | 80 | 10 | 212 | |
| Amy Dawson | 166 | 63 | 4 | 83 | 11 | 268 | |
| P.J. O'Donovan | 47 | 67 | 21 | 147 | 10 | 270 | |
| Yongjian Zhang | 52 | 101 | 2 | 104 | 10 | 276 | |
| Jeff Isaacson | 96 | 250 | 1 | 111 | 8 | 275 | |
| Lise M. van Wijk | 91 | 104 | 91 | 5 | 181 | ||
| Marthe M. de Jonge | 162 | 124 | 3 | 104 | 8 | 286 | |
| Elias Abdo Filho | 147 | 102 | 1 | 43 | 10 | 254 |
All Works
Loading papers...